Day 1 :
Bureau of Industry and Security, USA
Time : 10:00-10:40
Betty Lee has a PhD from Dartmouth Medical School, USA, M.S. Clinical Chemistry from the University of Windsor, Canada and M.S. Biochemistry from LSU Medical Center, USA. Dr. Lee completed her postdoctoral training at the National Institutes of Health, USA. She currently works as a Licensing Officer with the U.S. government. She educates industries and academia about the Export Administration Regulations (EAR) and participates in outreach. In addition, she participated in the policy review of the Executive Order titled “Optimizing the Security of Biological Select Agents and Toxins in the United States” signed by President Obama on July 2, 2010.
Biotechnology has the ability to improve health with pharmaceuticals, improve agricultural crops, improve the environment with new biofuels by reducing greenhouse gas emissions and improve crop insect resistance. Biotechnology is dual use technology because it can be used for legitimate manufacturing of pharmaceuticals and used for production of bioweapons. Civilian uses would include manufacturing medicines and industrial chemicals. The same equipment and technology could also be used to manufacture chemical or biological weapons. Therefore, biotechnology poses a challenge because of its dual nature.
To prevent misuse of biotechnology, many countries use export control or strategic trade to promote non-proliferation and as a deterrent to illicit use by terrorists. This is a means of controlling technology, manufacturing or processing equipment, chemicals and biological agents that may be used to manufacture chemical weapons or bioweapons.
Export Control is one of many tools to promote non-proliferation among countries and to prevent misuse of controlled technology, equipment, chemicals or biological agents. Many countries are members of multilateral regimes such as the Wassenaar Arrangement, Missile Technology Control Regime, Nuclear Suppliers Group and the Australia Group. In the case of biotechnology, the Australia Group maintains a list of controlled technology, software and commodities related to biotechnology and chemical processing. The U.S. government regulates the transfer of controlled commodities and technology, identical to the Australia Group List. This talk will explain the particulars of the Control List and how each country deters the illicit transfer of important equipment and technology to make weapons of mass destruction (WMD).
Institute of Natural Fibres and Medicinal Plants, Poland
Keynote: New perspectives in sericulture
Time : 10:40-11:20
Małgorzata Łochyńska has completed his PhD at the age of 26 years from Adam Mickiewicz University in Poznan. She is the head of Department of Silkworms Breeding and Mulberry Cultivation INF&MP in Poznan, Poland. She has published 70 papers in international journals and attended in 93 research conferences.
Numerous new applications of the mulberry silkworm (Bombyx mori L.) and the white mulberry (Morus alba L.) significantly increase the value of sericulture. Due to the bioactive substances contained in the leaves and silk, farmers are increasingly interested in the production of leaves as herbal raw material and silk cocoons. Additionally, products and by-products obtained from sericulture may be used in agriculture, medicine and industry. Beyond the commonly known sericulture attributes, silk proteins - fibroin and sericin – and almost 300 hemolymph are uncommon bioactive. The aim of this lecture is to present fascinating insect and its host and all possibilities to use them in human life.